Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Olive Oil With Omega 3 to Treat Stasis Dermatitis

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2007 by Assaf-Harofeh Medical Center.
Recruitment status was  Not yet recruiting
Information provided by:
Assaf-Harofeh Medical Center Identifier:
First received: January 10, 2007
Last updated: NA
Last verified: January 2007
History: No changes posted

January 10, 2007
January 10, 2007
January 2007
Not Provided
improvement in subjective and objective skin changes of patient: pain, edema, redness, size of involement,
Same as current
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
Olive Oil With Omega 3 to Treat Stasis Dermatitis
Phase 1 and 2 Study on the Efficacy and Side Effects of Olive Oil and Omega 3 Local Treatment in Stasis Dermatitis
Olive oil and Omega 3 have many anti inflammatory effects that may be beneficial in the inflammation and edema of chronic stasis dermatitis. The olive oil contains many mono unsaturated fatty acids and anti oxidants that may add to the well being of a diseased skin by improving cell membrane homeostasis.
Patients with chronic stasis dermatitis due to venous insufficiency will be treated with the study cream and as control we will use "Venoroutone" . Patients will be followed weekly at the clinic of the vascular surgery at Assaf Harofeh MC.
Phase 1
Phase 2
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Double-Blind
Primary Purpose: Treatment
Drug: olive oil and omega 3 in a combined cream
Not Provided
Sapino S, Carlotti ME, Peira E, Gallarate M. Hemp-seed and olive oils: their stability against oxidation and use in O/W emulsions. J Cosmet Sci. 2005 Jul-Aug;56(4):227-51.

*   Includes publications given by the data provider as well as publications identified by Identifier (NCT Number) in Medline.
Not yet recruiting
March 2007
Not Provided

Inclusion Criteria:

  • Patints with stasis dermatitis for 6 months at least

Exclusion Criteria:

  • skin ulceration or infection
18 Years to 80 Years   (Adult, Senior)
Contact: Refael Segal, MD, Prof` 972-8-9258640-3
Contact: Arie Bas, MD, Prof 972-8-9779188
Refael Segal
Not Provided
Not Provided
Not Provided
Not Provided
Assaf-Harofeh Medical Center
Not Provided
Principal Investigator: Arie Bass, MD Assaf Harofe MC
Assaf-Harofeh Medical Center
January 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP